1. Microarray Expression Profiling and Raman Spectroscopy Reveal Anti-Fatty Liver Action of Berberine in a Diet-Induced Larval Zebrafish Model
   Bo Chen et al, 2020, Frontiers in Pharmacology CrossRef
2. Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease
   Rou Tang et al, 2021, ACS Nano CrossRef
3. A comparative study on the effect of melatonin and orlistat combination versus orlistat alone on high fat diet-induced hepatic changes in the adult male albino rats (a histological and morphometric study)
   Sayed M. El-Sayed et al, 2024, Ultrastructural Pathology CrossRef
4. SOAT2, a new target of intestinal lipid-lowering drugs, mediates lipid uptake inhibition and lipid-lowering effects
   Jingjia Liang et al, 2023, Chinese Science Bulletin CrossRef
5. The protection afforded by Berberine against chemotherapy‐mediated nephropathy in rats involves regulation of the antioxidant axis
   Reham I. Alagal et al, 2023, Basic & Clinical Pharmacology & Toxicology CrossRef
6. Molecular updates on berberine in liver diseases: Bench to bedside
   Sapana Bansod et al, 2021, Phytotherapy Research CrossRef
7. Protective effects of syringic acid in nonalcoholic fatty liver in rats through regulation of Nrf2/HO‐1 signaling pathway
   Simiao Zhang et al, 2024, Journal of Biochemical and Molecular Toxicology CrossRef
8. Natural Aldose Reductase Inhibitor: A Potential Therapeutic Agent for Non-alcoholic Fatty Liver Disease
   Longxin Qiu et al, 2020, Current Drug Targets CrossRef
9. Baicalin attenuated metabolic dysfunction‐associated fatty liver disease by suppressing oxidative stress and inflammation via the p62–Keap1–Nrf2 signalling pathway in db/db mice
   Wen‐Jing Liu et al, 2023, Phytotherapy Research CrossRef
10. The place of berberine in the treatment of metabolic syndrome
    E. V. Shrayner et al, 2024, Experimental and Clinical Gastroenterology CrossRef
11. Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies
    Sichen Ren et al, 2021, Frontiers in Pharmacology CrossRef
12. Mechanism Involved in Fortification by Berberine in CDDP-Induced Nephrotoxicity
    Vipin K. Verma et al, 2020, Current Molecular Pharmacology CrossRef
13. Berberine mitigates acetamiprid-induced hepatotoxicity and inflammation via regulating endogenous antioxidants and NF-κB/TNF-α signaling in rats
    Annu Phogat et al, 2023, Environmental Science and Pollution Research CrossRef
14. Biological targets of berberine hydrochloride and the mechanisms by which it alleviates metabolic-associated fatty liver disease
    Jingjia Liang et al, 2023, Chinese Science Bulletin CrossRef
15. The therapeutic potential of typical plant‐derived compounds for the management of metabolic disorders
    Debajyoti Roy et al, 2024, Phytotherapy Research CrossRef
16. Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review
    Gabriela Svobodová et al, 2024, Archives of Toxicology CrossRef
17. Literature Review on the Use of Herbal Extracts in the Treatment of Non- Alcoholic Fatty Liver Disease
    Yutian Wang et al, 2022, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef